Time on boards
- Boards served
- 3
- Current seats
- 3
- Board service
- 6 years
- Director since
- 2023
6 years of board service in total across 3 boards, counting each seat separately. Longest: Neuronetics Inc., 3 years.
Neuronetics Inc.
Director
Anika Therapeutics Inc.
Director
TELA Bio Inc.
Director
Shareholder support
Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
Anika Therapeutics Inc. June 20, 202596.5%
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 17, 2026 | TELA Bio Inc. | Open-market purchase | +25,000 | $1.22 | $30,530 |
| Sep 16, 2026 | TELA Bio Inc. | Open-market purchase | +50,000 | $1.17 | $58,265 |
| Sep 15, 2026 | TELA Bio Inc. | Open-market purchase | +50,000 | $1.06 | $52,940 |
| Sep 14, 2026 | TELA Bio Inc. | Open-market purchase | +25,000 | $1.02 | $25,503 |
| Jul 15, 2026 | TELA Bio Inc. | Grant or award | +6,227 | $0.79 | $4,888 |
| Jun 18, 2026 | Anika Therapeutics Inc. | Grant or award | +10,402 | — | — |
| Jun 9, 2026 | TELA Bio Inc. | Grant or award | +11,925 | — | — |
| Jun 9, 2026 | TELA Bio Inc. | Grant or award | +11,675 | — | — |
| Mar 4, 2026 | MiMedx Group Inc | Grant or award | +371,094 | — | — |
| Jun 20, 2025 | Anika Therapeutics Inc. | Grant or award | +14,164 | — | — |
| May 2, 2025 | MiMedx Group Inc | Open-market purchase | +200,000 | $6.34 | $1,268,000 |
| Mar 3, 2025 | MiMedx Group Inc | Grant or award | +223,268 | — | — |
| Jul 9, 2024 | Anika Therapeutics Inc. | Grant or award | +5,771 | — | — |
| Jun 3, 2024 | Anika Therapeutics Inc. | Grant or award | +468 | — | — |
| Jun 23, 2023 | MiMedx Group Inc | Open-market purchase | +42,025 | $6.50 | $273,163 |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.